Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial - Concepedia

Concepedia

Publication | Open Access

Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial

DOI Full Paper Access

109

Citations

28

References

2018

Year

Tian Zhao, Charmaine Griffiths, Emma L Arbon, Annette Hubsch, Fotini Kaloyirou, Joanna Helmy, Stephen P. Hoole, James H.F. Rudd, G. C. Wood, Keith Burling,

Abstract

NCT03113773; Pre-results.

References

	Year	Citations

Page 1